KRDI in Transplant-Eligible MM
Summary
Third Opinion Trial Synopsis:
This study is testing how well a new medicine works for people with a type of cancer called multiple myeloma. The medicine has four different drugs in it. The study is for people who have just been diagnosed with the cancer and may need a special treatment called a stem cell transplant.
This study is testing how well a new medicine works for people with a type of cancer called multiple myeloma. The medicine has four different drugs in it. The study is for people who have just been diagnosed with the cancer and may need a special treatment called a stem cell transplant.
*Third Opinion AI Generated Synopsis
Trial Summary
This research study is testing the efficacy of an experimental drug combination for people with newly diagnosed multiple myeloma that are eligible for a stem cell transplant. The names of the study drugs involved in this study are: Carfilzomib Isatuximab Lenalidomide Dexamethasone
This research study is testing the efficacy of an experimental drug combination for people with newly diagnosed multiple myeloma that are eligible for a stem cell transplant. The names of the study drugs involved in this study are: Carfilzomib Isatuximab Lenalidomide Dexamethasone
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: